TGFB1 and cholangiocarcinoma: Secondly, TGF-β1 (≥33.4 ng/mL) provided diagnostic accuracy in 8/12 (67%) and 90% diagnostic yield of CCA patients with CA19-9-low levels (Figure 4C).